Byrne Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,000
| Closed | -$19K | – | 558 |
|
|
2024
Q2 | $19K | Buy |
14,000
+10,800
| +338% | +$14.7K | 0.01% | 299 |
|
|
2024
Q1 | $12K | Buy |
+3,200
| New | +$12K | 0.01% | 342 |
|
|
2022
Q4 | – | Sell |
-5,140
| Closed | -$30K | – | 549 |
|
|
2022
Q3 | $30K | Buy |
5,140
+1,840
| +56% | +$10.7K | 0.02% | 248 |
|
|
2022
Q2 | $15K | Buy |
+3,300
| New | +$15K | 0.01% | 318 |
|